Categories: Top News

X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences

BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in three upcoming investor conferences in September 2024:

Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 2:35 PM EDT
Format: Fireside Chat and 1×1 Meetings
Webcast Link

Wells Fargo Healthcare Conference
Date: Thursday, September 5, 2024
Format: 1×1 Meetings

Cantor Fitzgerald Global Healthcare Conference
Date: Tuesday, September 17, 2024
Time: 3:40 PM EDT
Format: Fireside Chat and 1×1 Meetings
Webcast Link

The live webcasts for the Morgan Stanley 22nd Annual Global Healthcare Conference and the Cantor Fitzgerald Global Healthcare Conference will also be accessible through the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com. Following the completion of these fireside chats, the webcast replays will be available on the X4 website.

For interested investors looking to schedule one-on-one meetings with company management, please contact your respective Morgan Stanley, Wells Fargo, or Cantor Fitzgerald representatives.

About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI™ (mavorixafor) capsules in its first indication. We are also evaluating the use of mavorixafor in additional potential indications. X4 corporate headquarters are in Boston, Massachusetts and our research center of excellence is in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.

Company Contact:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com

Investor Contact:
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576

GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Recent Posts

Tech-Focused Executive Search Firm Riviera Partners Welcomes Back Sam Wholley as Managing Partner

San Francisco, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Riviera Partners, the leading executive search…

10 minutes ago

Toronto Kids Fashion Week Launches in Winnipeg for the First Time – Model Casting Happening April 27 at Hotel Fort Garry

This is your child’s chance to empower themselves, build confidence, and shine on stage! For…

1 hour ago

Air Methods Stands Ready to Deliver Critical Air Medical Service at Talladega

Helicopter will be onsite for racers and crew members needing emergency air transport Life Saver…

1 hour ago

Azuria Water Solutions Announces the Acquisition of TSW Utility Solutions, Inc., AM-Liner East, Inc., and C.K. Masonry Company, Inc.

A Leader of Technology-Enabled Water Solutions Has Welcomed Three Companies This YearST. LOUIS, April 21, 2025…

1 hour ago

Adventure Travelers Go Green: 60% Now Prioritize Sustainability Ahead of Earth Day

ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- With Earth Day on the horizon,…

2 hours ago

Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency

DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force…

2 hours ago

This website uses cookies.